Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain
Howard S Smith,1 Timothy R Deer21Albany Medical College, Department of Anesthesiology, Albany, New York, USA; 2The Center for Pain Relief, Clinical Professor, West Virginia, University, Charleston, West Virginia, USAAbstract: Ziconotide is a conopeptide intrathecal (IT) analgesic which is approved b...
Main Authors: | Howard S Smith, Timothy R Deer |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-07-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/safety-and-efficacy-of-intrathecal-ziconotide-in-the-management-of-sev-a3332 |
Similar Items
-
Intrathecal pain management with ziconotide: Time for consensus?
by: Georgios Matis, et al.
Published: (2021-03-01) -
Serious pain treatment with intrathecal ziconotide pathway - clinical case
by: Giovanni Nicotera, et al.
Published: (2008-04-01) -
Resolution of chronic migraine headaches with intrathecal ziconotide: a case report
by: Narain S, et al.
Published: (2015-09-01) -
Simultaneous Determination of Sufentanil and Ziconotide in Combination for Intrathecal Analgesia by UPLC-UV
by: Sorrieul Jérémy, et al.
Published: (2016-12-01) -
Ziconotide in severe, drug-resistant cancer pain. preliminary experience
by: Angelo Lavano
Published: (2008-12-01)